Cargando…
Deregulation of TLR4 signaling pathway characterizes Bicuspid Aortic valve syndrome
Bicuspid aortic valve (BAV) disease is recognized to be a syndrome with a complex and multifaceted pathophysiology. Its progression is modulated by diverse evolutionary conserved pathways, such as Notch-1 pathway. Emerging evidence is also highlighting the key role of TLR4 signaling pathway in the a...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667442/ https://www.ncbi.nlm.nih.gov/pubmed/31363123 http://dx.doi.org/10.1038/s41598-019-47412-0 |
_version_ | 1783440038739050496 |
---|---|
author | Balistreri, Carmela R. Marullo, Antonino G. M. Madonna, Michele Cavarretta, Elena Allegra, Alberto Cesarini, Valeriana Iaccarino, Alessandra Schiavon, Sonia Peruzzi, Mariangela Greco, Ernesto Sciarretta, Sebastiano Pisano, Calogera Ruvolo, Giovanni Torella, Michele Frati, Giacomo |
author_facet | Balistreri, Carmela R. Marullo, Antonino G. M. Madonna, Michele Cavarretta, Elena Allegra, Alberto Cesarini, Valeriana Iaccarino, Alessandra Schiavon, Sonia Peruzzi, Mariangela Greco, Ernesto Sciarretta, Sebastiano Pisano, Calogera Ruvolo, Giovanni Torella, Michele Frati, Giacomo |
author_sort | Balistreri, Carmela R. |
collection | PubMed |
description | Bicuspid aortic valve (BAV) disease is recognized to be a syndrome with a complex and multifaceted pathophysiology. Its progression is modulated by diverse evolutionary conserved pathways, such as Notch-1 pathway. Emerging evidence is also highlighting the key role of TLR4 signaling pathway in the aortic valve pathologies and their related complications, such as sporadic ascending aorta aneurysms (AAA). Consistent with these observations, we aimed to evaluate the role of TLR4 pathway in both BAV disease and its common complication, such as AAA. To this aim, 70 subjects with BAV (M/F 50/20; mean age: 58.8 ± 14.8 years) and 70 subjects with tricuspid aortic valve (TAV) (M/F 35/35; mean age: 69.1 ± 12.8 years), with and without AAA were enrolled. Plasma assessment, tissue and gene expression evaluations were performed. Consistent with data obtained in the previous study on immune clonotypic T and B altered responses, we found reduced levels of systemic TNF-α, IL-1, IL-6, IL-17 cytokines in BAV cases, either in the presence or absence of AAA, than TAV cases (p < 0.0001 by ANOVA test). Interestingly, we also detected reduced levels of s-TLR4 in BAV cases with or without AAA in comparison to the two groups of TAV subjects (p < 0.0001 by ANOVA test). These results may suggest a deregulation in the activity or in the expression of TLR4 signaling pathway in all BAV cases. Portrait of these data is, indeed, the significantly decreased gene expression of inflammatory cytokines and TLR4, in both normal and aneurysmatic tissue samples, from BAV with AAA than TAV with AAA. In conclusion, our study demonstrates that subjects with BAV display a significant deregulation of TLR4 signaling pathway paralleled by a deregulation of Notch-1 pathway, as previously showed. This data suggests that the crosstalk between the Notch-1 and TLR4 signaling pathways may play a crucial role in both physiological embryological development, and homeostasis and functionality of aortic valve in adult life. |
format | Online Article Text |
id | pubmed-6667442 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-66674422019-08-06 Deregulation of TLR4 signaling pathway characterizes Bicuspid Aortic valve syndrome Balistreri, Carmela R. Marullo, Antonino G. M. Madonna, Michele Cavarretta, Elena Allegra, Alberto Cesarini, Valeriana Iaccarino, Alessandra Schiavon, Sonia Peruzzi, Mariangela Greco, Ernesto Sciarretta, Sebastiano Pisano, Calogera Ruvolo, Giovanni Torella, Michele Frati, Giacomo Sci Rep Article Bicuspid aortic valve (BAV) disease is recognized to be a syndrome with a complex and multifaceted pathophysiology. Its progression is modulated by diverse evolutionary conserved pathways, such as Notch-1 pathway. Emerging evidence is also highlighting the key role of TLR4 signaling pathway in the aortic valve pathologies and their related complications, such as sporadic ascending aorta aneurysms (AAA). Consistent with these observations, we aimed to evaluate the role of TLR4 pathway in both BAV disease and its common complication, such as AAA. To this aim, 70 subjects with BAV (M/F 50/20; mean age: 58.8 ± 14.8 years) and 70 subjects with tricuspid aortic valve (TAV) (M/F 35/35; mean age: 69.1 ± 12.8 years), with and without AAA were enrolled. Plasma assessment, tissue and gene expression evaluations were performed. Consistent with data obtained in the previous study on immune clonotypic T and B altered responses, we found reduced levels of systemic TNF-α, IL-1, IL-6, IL-17 cytokines in BAV cases, either in the presence or absence of AAA, than TAV cases (p < 0.0001 by ANOVA test). Interestingly, we also detected reduced levels of s-TLR4 in BAV cases with or without AAA in comparison to the two groups of TAV subjects (p < 0.0001 by ANOVA test). These results may suggest a deregulation in the activity or in the expression of TLR4 signaling pathway in all BAV cases. Portrait of these data is, indeed, the significantly decreased gene expression of inflammatory cytokines and TLR4, in both normal and aneurysmatic tissue samples, from BAV with AAA than TAV with AAA. In conclusion, our study demonstrates that subjects with BAV display a significant deregulation of TLR4 signaling pathway paralleled by a deregulation of Notch-1 pathway, as previously showed. This data suggests that the crosstalk between the Notch-1 and TLR4 signaling pathways may play a crucial role in both physiological embryological development, and homeostasis and functionality of aortic valve in adult life. Nature Publishing Group UK 2019-07-30 /pmc/articles/PMC6667442/ /pubmed/31363123 http://dx.doi.org/10.1038/s41598-019-47412-0 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Balistreri, Carmela R. Marullo, Antonino G. M. Madonna, Michele Cavarretta, Elena Allegra, Alberto Cesarini, Valeriana Iaccarino, Alessandra Schiavon, Sonia Peruzzi, Mariangela Greco, Ernesto Sciarretta, Sebastiano Pisano, Calogera Ruvolo, Giovanni Torella, Michele Frati, Giacomo Deregulation of TLR4 signaling pathway characterizes Bicuspid Aortic valve syndrome |
title | Deregulation of TLR4 signaling pathway characterizes Bicuspid Aortic valve syndrome |
title_full | Deregulation of TLR4 signaling pathway characterizes Bicuspid Aortic valve syndrome |
title_fullStr | Deregulation of TLR4 signaling pathway characterizes Bicuspid Aortic valve syndrome |
title_full_unstemmed | Deregulation of TLR4 signaling pathway characterizes Bicuspid Aortic valve syndrome |
title_short | Deregulation of TLR4 signaling pathway characterizes Bicuspid Aortic valve syndrome |
title_sort | deregulation of tlr4 signaling pathway characterizes bicuspid aortic valve syndrome |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667442/ https://www.ncbi.nlm.nih.gov/pubmed/31363123 http://dx.doi.org/10.1038/s41598-019-47412-0 |
work_keys_str_mv | AT balistrericarmelar deregulationoftlr4signalingpathwaycharacterizesbicuspidaorticvalvesyndrome AT marulloantoninogm deregulationoftlr4signalingpathwaycharacterizesbicuspidaorticvalvesyndrome AT madonnamichele deregulationoftlr4signalingpathwaycharacterizesbicuspidaorticvalvesyndrome AT cavarrettaelena deregulationoftlr4signalingpathwaycharacterizesbicuspidaorticvalvesyndrome AT allegraalberto deregulationoftlr4signalingpathwaycharacterizesbicuspidaorticvalvesyndrome AT cesarinivaleriana deregulationoftlr4signalingpathwaycharacterizesbicuspidaorticvalvesyndrome AT iaccarinoalessandra deregulationoftlr4signalingpathwaycharacterizesbicuspidaorticvalvesyndrome AT schiavonsonia deregulationoftlr4signalingpathwaycharacterizesbicuspidaorticvalvesyndrome AT peruzzimariangela deregulationoftlr4signalingpathwaycharacterizesbicuspidaorticvalvesyndrome AT grecoernesto deregulationoftlr4signalingpathwaycharacterizesbicuspidaorticvalvesyndrome AT sciarrettasebastiano deregulationoftlr4signalingpathwaycharacterizesbicuspidaorticvalvesyndrome AT pisanocalogera deregulationoftlr4signalingpathwaycharacterizesbicuspidaorticvalvesyndrome AT ruvologiovanni deregulationoftlr4signalingpathwaycharacterizesbicuspidaorticvalvesyndrome AT torellamichele deregulationoftlr4signalingpathwaycharacterizesbicuspidaorticvalvesyndrome AT fratigiacomo deregulationoftlr4signalingpathwaycharacterizesbicuspidaorticvalvesyndrome |